Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Common Equity: 2021-2025

Historic Common Equity for biote (BTMD) over the last 5 years, with Q3 2025 value amounting to -$72.8 million.

  • biote's Common Equity rose 4418.45% to -$72.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.8 million, marking a year-over-year increase of 4418.45%. This contributed to the annual value of -$105.9 million for FY2024, which is 18984.84% down from last year.
  • As of Q3 2025, biote's Common Equity stood at -$72.8 million, which was up 4418.45% from -$85.1 million recorded in Q2 2025.
  • biote's 5-year Common Equity high stood at $10.7 million for Q1 2022, and its period low was -$143.3 million during Q2 2024.
  • Its 5-year average for Common Equity is -$58.2 million, with a median of -$70.8 million in 2022.
  • Examining YoY changes over the last 5 years, biote's Common Equity showed a top increase of 11491.99% in 2022 and a maximum decrease of 513628.97% in 2022.
  • Quarter analysis of 5 years shows biote's Common Equity stood at $4.1 million in 2021, then crashed by 1512.7% to -$58.3 million in 2022, then skyrocketed by 37.29% to -$36.5 million in 2023, then tumbled by 189.85% to -$105.9 million in 2024, then soared by 31.32% to -$72.8 million in 2025.
  • Its last three reported values are -$72.8 million in Q3 2025, -$85.1 million for Q2 2025, and -$90.0 million during Q1 2025.